ASSESSMENT OF CORRELATION BETWEEN HIV INFECTION AND TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE
https://doi.org/10.21292/2075-1230-2018-96-7-25-32
Abstract
Human immunodeficiency virus (HIV) and tuberculosis with multiple drug resistance (MDR TB) are becoming the major problem for national tuberculosis control programs. Conclusions made by various studies investigating the association of HIV infection and multiple drug resistance of tuberculous mycobacteria in tuberculosis patients are not always unambiguous and evident.
The objective: to summarize data on the correlation between HIV infection and MDR TB among new cases through the systematic review of published results of studies.
Research methods. The quality, accuracy and authenticity of the initial data were assessed. Approximating functions of changes in HIV-TB-MDR and TB-MDR were built for new cases basing on the data of 11 selected studies. The general effect of HIV infection impact factor on TB-MDR was assessed for the studies included into the analysis.
Results. Data analysis for the consolidated group of new cases showed that the assessment of the risk of MDR detection was higher in those with TB/HIV co-infection (OR 2.76; 95% CI 2.35-3.24) versus HIV negative tuberculosis patients, which provided the evidence of the existing positive epidemiological correlation between the positive HIV status and MDR TB.
About the Authors
Sergey A. Popov
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Russian Federation
Russian Federation
Candidate of Medical Sciences, Head of Microbiological Research Laboratory.
4, Dostoevsky St., Moscow, 127473
Tamara P. Sabgayda
National Medical Research Center of Phthisiopulmonology and Infectious Diseases;
Central Research Institute for Public Health Organization and Informatization
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, Leading Researcher
4, Dostoevsky St., Moscow, 127473
Tatiana S. Radina
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Russian Federation
Russian Federation
Academic Secretary.
4, Dostoevsky St., Moscow, 127473
References
1. Dembitskiy S.S. Meta- analysis: key notions and basics of calculations (using cross-national research Sotsiologiya: Teoriya, Metody, Marketing, 2012, no. 3, pp. 160-174. (In Russ.)
2. Zhdanova S.N., Ogarkov O.B., Zarbuev А.N., Untanova L.S., Savilov E.D. Investigation of genetic diversity of Mycobacterium tuberculosis with HIV co-infection in the East Siberian Region. Acta Biomedica Scientifica, 2012, vol. 87, no. 5-1, pp. 47-50. (In Russ.)
3. Zaytseva E.V., Vladimirov K.B., Ivanov А.K. Drug resistance of tuberculous mycobacteria in HIV patients in the penitentiary system of St. Petersburg and Leningrad Region. Tuberculosis and Lung Diseases, 2010, no. 9, pp. 25-28. (In Russ.)
4. WHO Information Bulletin. October, 2017, WHO, /URL: http://www.who.int/mediacentre/factsheets/fs104/ru/ (In Russ.)
5. Koretskaya N.M., Bolshakova I.А. Biological properties of mycobacteria in HIV-negative and HIV-positive patients suffering from disseminated pulmonary tuberculosis. Sibirskoye Meditsinskoye Obozreniye, 2012, vol. 76, no. 4, pp. 62-66. (In Russ.)
6. Koretskaya N.M., Bolshakova I.А. Typical features of primary drug resistance and viability of mycobacteria in tuberculosis patients with concurrent HIV-infection. Tuberculosis and Lung Diseases, 2017, vol. 95, no. 2, pp. 16-20. (In Russ.)
7. Koretskaya N.M., Narkevich А.N. Multiple drug resistance in new pulmonary tuberculosis patients in Krasnoyarskiy Kray. Аkadem. Journal Zapadnoy Sibiri, 2013, no. 1, pp. 51-52. (In Russ.)
8. Koretskaya N.M., Narkevich А.N. Detection and characteristics of respiratory tuberculosis in HIV infection. Аkadem. Journal Zapadnoy Sibiri, 2013, no. 1, pp. 52-53. (In Russ.)
9. Lecheniye tuberkuleza. Rekomendatsii. (chervertoye izdaniye). (Russ. ed.: Treatment of tuberculosis: guidelines, 4th ed.) Geneva, Regional Office for Europe, 2011, 183 p.
10. Markelov Yu.M., Narvskaya O.V. Circulation of drug resistant tuberculosis strains on the territory of Karelia Republic. Tuberculosis and Lung Diseases, 2010, no. 2, pp. 54-57. (In Russ.)
11. Mordyk А.V., Tsygankova E.А., Puzyreva L.V., Turitsa А.А. Anti-tuberculosis immunity and ways of its formation (literature review). Dalnevostochny Med. Journal, 2014, no. 1, pp. 126-130. (In Russ.)
12. Nesterenko A.V. Clinical course of tuberculosis in HIV infected patients. Ftisiatriya i Pulmonologiya, 2013, vol. 7, no. 2, pp. 29-33. (In Russ.)
13. Sinitsin M.V., Bogadelnikova I.V., Perelman M.I. Glutoxim – 10 years in tuberculosis control (tuberculosis treatment experience). Tuberculosis and Lung Diseases, 2010, no. 10, pp. 3-9. (In Russ.)
14. Sotsialnoznachimye zabolevaniya naseleniya Rossii v 2016 godu. (Statisticheskie materialy). [Socially important diseases of the Russian population in 2016. (Statistic materials)]. 2017, Moscow, TSNIIOIZ Publ., 64 p. URL:http://mednet.ru/ru/statistika/soczialno-znachimye-zabolevaniya.html
15. Ten M.B., Lityaeva L.А., Parfenova T.А. Clinical and epidemiological characteristics of tuberculosis in children, born by HIV infected mothers in Orenburg Region. Infectious Diseases (Infektsionnye Bolezni), 2011, vol. 9, no. 2, pp. 97-99. (In Russ.)
16. An introduction to meta-analysis. The Cochrane Collaboration open learning material/URL: http://www.cochrane-net.org/openlearning/html/mod3.htm
17. Anti-tuberculosis drug resistance among tuberculosis patients in Ukraine and risk factors for MDR-TB. Results of the first national survey, 2013-2014/World Health Organization. 2016, Copenhagen, 28 p
18. Ausina V., Riutort N., Vinado B., Manterola J.M., Ruiz Manzano J., Rodrigo C., Matas L., Giménez M., Tor J., Roca J. Prospective study of drug-resistant tuberculosis in a Spanish urban population including patients at risk for HIV infection. Eur. J. Clin. Microbiol. Infect. Dis., 1995, vol. 14, pp. 105-110.
19. Burki T. Surveillance, co-infection, resistance: tuberculosis in Europe. Lancet Infect. Diseases, 2011, vol. 11, no. 5, pp. 350-351.
20. Campos P.E., Suarez P.G., Sanchez J., Zavala D., Arevalo J., Ticona E., Nolan C.M., Hooton T.M., Holmes K.K. Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Emerg. Infect. Dis., 2003, vol. 9, pp. 1571-1578.
21. Chum H.J., O’Brien R.J., Chonde T.M., Graf P., Rieder H.L. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993. AIDS, 1996, vol. 10, pp. 299-309.
22. Churchyard G.J., Corbett E.L., Klinschmidt I., Mulder D., De Cock K.M. Drug-resistant tuberculosis in South African gold miners. – P incidence and associated factors. Int. J. Tuberc. Lung. Dis., 2000, vol. 4, pp. 433-440.
23. Conaty S.J., Hayawrd A.C., Story A., Glynn J.R., Drobniewski F.A., Watson J.M. Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance. Epidemiol. Infect., 2004, vol. 132, pp. 1099-1108.
24. Corbett E.L., Watt C.J., Walker N., Maher D., Williams B.G., Raviglione M.C., Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med., 2003, vol. 163, no. 9, pp. 1009-1021.
25. Dubrovina I., Miskinis K., Lyepshina S., Yann Y., Hoffmann H., Zaleskis R., Nunn P., Zignol M. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics. Int. J. Tuberc. Lung. Dis., 2008, vol. 12, pp. 756-762.
26. Espinal M.A., Laserson K., Camacho M., Fusheng Z., Kim S.J., Tlali R.E., Smith I., Suarez P., Antunes M.L., George A.G., Martin-Casabona N., Simelane P., Weyer K., Binkin N., Raviglione M.C. Determinant of drug-resistant tuberculosis: analysis of 11 countries. Int. J. Tuberc. Lung. Dis., 2001, vol. 5, pp. 887-893.
27. Global report on surveillance and response on multidrug and extensively drug-resistant TB (M/XDR-TB)// WHO report.WHO/HTM/TB/3/. 2010, Geneva,
28. Haar C.H., Cobelens F.G., Kalisvaart N.A., van der Have J.J., van Gerven P.J., van Soolingen D. Tuberculosisdrug resistance and HIV infection, the Netherlands. Emerg. Infect. Dis., 2007, vol. 13, no. 5, pp. 776-778.
29. Harries A.D., Zachariah R., Lawn S.D. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. Int. J. Tuberc. Lung. Dis., 2008, no. 12, pp. 39-43.
30. van den Hof S., Tursynbayeva A., Abildaev T., Adenov M., Pak S., Ismailov S. HIV and multidrug-resistant tuberculosis: overlapping risk factors. Europ. Respir. J., 2015, vol. 45, pp. 567-569. ‒ DOI: 10.1183/09031936.00131014
31. Jason A.J.R., Shah N.S., Weissman D., Moll A.P., Friedland G., Gandhi N.R. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community. PLoS ONE, 2010, vol. 5, no. 12, pp. e15735. doi:10.1371/ journal.pone.0015735
32. Joseph P., Severe P., Ferdinand S., Goh K.S., Sola C., Haas D.W., Johnson W.D., Rastogi N., Pape J.W., Fitzgerald D.W. Multi-drug resistant tuberculosis at an HIV testing center in Haiti. AIDS, 2006, vol. 20, pp. 415-418.
33. Lawn S.D., Churchyard G. Epidemiology of HIV-associated tuberculosis. Current Opinion in HIV and AIDS. 2009, no. 4, pp. 325-333.
34. Mac-Arthur A., Gloyd S., Perdiagao P., Noya A., Sacarlal J., Kreiss J. Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. Int. J. Tuberc. Lung. Dis., 2001, vol. 5, pp. 894-902.
35. MesfinY.M., Hailemaria D., Biadglig S., Kibret K.T. Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS ONE, 2014, vol. 9, no. 1, pp. e82235. doi:10.1371/journal.pone.0082235
36. Pereira M., Tripathy S., Inamdar V., Ramesh K., Bhavsar M., Date A., Iyyer R., Acchammachary A., Mehendale S., Risbud A. Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian. J. Med. Res., 2005, vol. 121, pp. 235-239.
37. Post F.A., Wood R. HIV infection is not associated with an increased rate of drug-resistant tuberculosis. S. Afr. Med. J., 1997, vol. 87, pp. 903.
38. Quy H.T., Buu T.N., Cobelens F.G.J., Lan N.T.N., Lambregts C.S.B., Borgdorff M.W. Drug resistance among smear-positive tuberculosispatients in Ho Chi Minh City, Vietnam. Int. J. Tuberc. Lung. Dis., 2006, vol. 10, pp. 160-166.
39. Schwoebel V., Decludt B., de Benoist A.C., Haeghebaert S., Torrea G. et al. Multidrug resistant tuberculosis in France 1992-4: two case-control studies. BMJ, 1998, vol. 317, pp. 630-631.
40. Singh M.M., Chopra K.K. MDR-TB current issues. Indian. J. Tuberc., 2004, vol. 51, pp. 1-3.
41. Wells D.C., Peter C.J., Nelson L.J., Laserson K.F., Holtz T.H., Finlay A., Castro K.G., Weyer K. HIV infection and multidrug-resistant tuberculosis-the perfect storm. J. Infect. Dis., 2007, vol. 196, suppl. 1, pp. S86-S88.
42. Yoshiyama T., Supawitkul S., Kunyanone N., Riengthong D., Yanai H., Abe C., Ishikawa N., Akarasewi P., Payanandana V., Mori T. Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand. Int. J. Tuberc. Lung. Dis., 2001, vol. 5, pp. 32-39.
Review
For citations:
Popov S.A., Sabgayda T.P., Radina T.S. ASSESSMENT OF CORRELATION BETWEEN HIV INFECTION AND TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE. Tuberculosis and Lung Diseases. 2018;96(7):25-32. (In Russ.) https://doi.org/10.21292/2075-1230-2018-96-7-25-32
Views:
1406
Email this article 